ÂÜÀòÂÒÂ×

Muriel Gazin is a seasoned medical professional currently serving as the Medical Advisor for Inflammation BeLux at Galapagos since June 2019, where responsibilities include leading the medical strategy for Jyseleca (filgotinib) in Rheumatoid Arthritis. Previous roles include Medical Science Liaison in Rheumatology, Global Clinical Project Manager at Biocartis, and Clinical Research Associate at IQVIA. Muriel's academic background includes a PhD in Medical Sciences from the University of Antwerp, and a Master's degree in Bioscience Engineering from KU Leuven. Muriel has extensive experience in clinical development, medical affairs, and research, underscored by a strong foundation in microbiology and biotechnology.